Ang-1 was investigated as a prognostic biomarker in only one study conducted exclusively in patients with iPAH, in which Ang-1 showed no associations with disease severity or outcome [10]. This evidence concerns the gene ANGPT1 and idiopathic pulmonary arterial hypertension.